Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
Clinical trial NCT07108387 · RECRUITING
Trial details
- NCT number
- NCT07108387
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-05
- Primary completion
- 2027-06-11
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.